These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 21371143)
1. Maternal red blood cell alloimmunisation in south western Uganda. Natukunda B; Mugyenyi G; Brand A; Schonewille H Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143 [TBL] [Abstract][Full Text] [Related]
2. Alloimmunisation during pregnancy in Greece: need for nationwide HDFN prevention programme. Foudoulaki-Paparizos L; Valsami S; Bournas N; Tsantes A; Grapsas P; Mantzios G; Travlou A; Politou M Transfus Med; 2013 Aug; 23(4):254-9. PubMed ID: 23826966 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Natukunda B; Schonewille H; van de Watering L; Brand A Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889 [TBL] [Abstract][Full Text] [Related]
4. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme. Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943 [TBL] [Abstract][Full Text] [Related]
5. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570 [TBL] [Abstract][Full Text] [Related]
6. Anti-D alloimmunisation in pregnant women with DEL phenotype in China. Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335 [TBL] [Abstract][Full Text] [Related]
7. RhD haemolytic disease of the fetus and the newborn. Urbaniak SJ; Greiss MA Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia. Pal M; Williams B Pathology; 2015 Feb; 47(2):151-5. PubMed ID: 25551305 [TBL] [Abstract][Full Text] [Related]
10. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women. Karim F; Moiz B; Kamran N Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481 [TBL] [Abstract][Full Text] [Related]
11. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan. Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030 [TBL] [Abstract][Full Text] [Related]
12. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204 [TBL] [Abstract][Full Text] [Related]
13. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation. Walsh CA; Russell N; McAuliffe FM; Higgins S; Mahony R; Carroll S; McParland P Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):235-9. PubMed ID: 24075591 [TBL] [Abstract][Full Text] [Related]
14. [Foetal-maternal alloimmunizations in the South-East area of the Venice province]. Gessoni G; Valverde S; Giacomini A; Antico F; Salvadego M; Arreghini N; De Fusco G; Fezzi M; Marchiori G; Manoni F Minerva Ginecol; 2002 Aug; 54(4):333-8. PubMed ID: 12114866 [TBL] [Abstract][Full Text] [Related]
15. The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion-induced red blood cell alloimmunisation. Oud JA; Evers D; de Haas M; de Vooght KMK; van de Kerkhof D; Som N; Péquériaux NCV; Hudig F; Albersen A; van der Bom JG; Zwaginga JJ Br J Haematol; 2021 Nov; 195(4):604-611. PubMed ID: 34346067 [TBL] [Abstract][Full Text] [Related]
16. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Tormey CA; Fisk J; Stack G Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy. Koelewijn JM; Vrijkotte TG; de Haas M; van der Schoot CE; Bonsel GJ BJOG; 2009 Apr; 116(5):655-64. PubMed ID: 19210505 [TBL] [Abstract][Full Text] [Related]
18. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Natukunda B; Schonewille H; Ndugwa C; Brand A Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949 [TBL] [Abstract][Full Text] [Related]
19. Detection of anti-D in D- recipients transfused with D+ red blood cells. Yazer MH; Triulzi DJ Transfusion; 2007 Dec; 47(12):2197-201. PubMed ID: 17714422 [TBL] [Abstract][Full Text] [Related]
20. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus. Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]